215 related articles for article (PubMed ID: 26315555)
1. Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies.
Zhong S; Chen L; Zhang X; Yu D; Tang J; Zhao J
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1645-55. PubMed ID: 26315555
[TBL] [Abstract][Full Text] [Related]
2. Aspirin might reduce the incidence of breast cancer: An updated meta-analysis of 38 observational studies.
Cao Y; Tan A
Medicine (Baltimore); 2020 Sep; 99(38):e21917. PubMed ID: 32957311
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019.
Ma S; Guo C; Sun C; Han T; Zhang H; Qu G; Jiang Y; Zhou Q; Sun Y
Clin Breast Cancer; 2021 Dec; 21(6):552-565. PubMed ID: 33741292
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.
Baandrup L; Faber MT; Christensen J; Jensen A; Andersen KK; Friis S; Kjaer SK
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):245-55. PubMed ID: 23240575
[TBL] [Abstract][Full Text] [Related]
5. Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005.
Mangiapane S; Blettner M; Schlattmann P
Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):115-24. PubMed ID: 17955496
[TBL] [Abstract][Full Text] [Related]
6. Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies.
Zhong S; Zhang X; Chen L; Ma T; Tang J; Zhao J
Breast Cancer Res Treat; 2015 Feb; 150(1):199-207. PubMed ID: 25677744
[TBL] [Abstract][Full Text] [Related]
7. Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.
Qiao Y; Yang T; Gan Y; Li W; Wang C; Gong Y; Lu Z
BMC Cancer; 2018 Mar; 18(1):288. PubMed ID: 29534696
[TBL] [Abstract][Full Text] [Related]
8. Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants.
Lu L; Shi L; Zeng J; Wen Z
Oncotarget; 2017 Jun; 8(25):40389-40401. PubMed ID: 28418881
[TBL] [Abstract][Full Text] [Related]
9. Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis.
Zhao YS; Zhu S; Li XW; Wang F; Hu FL; Li DD; Zhang WC; Li X
Breast Cancer Res Treat; 2009 Sep; 117(1):141-50. PubMed ID: 18979210
[TBL] [Abstract][Full Text] [Related]
10. Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies.
Tang L; Hu H; Liu H; Jian C; Wang H; Huang J
Oncotarget; 2016 Oct; 7(40):65196-65207. PubMed ID: 27533449
[TBL] [Abstract][Full Text] [Related]
11. Aspirin use and breast cancer risk: a meta-analysis.
Luo T; Yan HM; He P; Luo Y; Yang YF; Zheng H
Breast Cancer Res Treat; 2012 Jan; 131(2):581-7. PubMed ID: 21898115
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of aspirin use and risk of lung cancer shows notable results.
Hochmuth F; Jochem M; Schlattmann P
Eur J Cancer Prev; 2016 Jul; 25(4):259-68. PubMed ID: 26067033
[TBL] [Abstract][Full Text] [Related]
13. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson TW; Anderson KE; Lazovich D; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
15. Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis.
Zhang D; Bai B; Xi Y; Wang T; Zhao Y
Gynecol Oncol; 2016 Aug; 142(2):368-77. PubMed ID: 27151430
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
Takkouche B; Regueira-Méndez C; Etminan M
J Natl Cancer Inst; 2008 Oct; 100(20):1439-47. PubMed ID: 18840819
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.
Huang XZ; Gao P; Sun JX; Song YX; Tsai CC; Liu J; Chen XW; Chen P; Xu HM; Wang ZN
Cancer Causes Control; 2015 Apr; 26(4):589-600. PubMed ID: 25701248
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of regular aspirin use and the risk of breast cancer.
Egan KM; Stampfer MJ; Giovannucci E; Rosner BA; Colditz GA
J Natl Cancer Inst; 1996 Jul; 88(14):988-93. PubMed ID: 8667430
[TBL] [Abstract][Full Text] [Related]
19. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI
JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893
[TBL] [Abstract][Full Text] [Related]
20. Can Aspirin Reduce the Risk of Endometrial Cancer?: A Systematic Review and Meta-analysis of Observational Studies.
Zhang D; Bai B; Xi Y; Zhao Y
Int J Gynecol Cancer; 2016 Jul; 26(6):1111-20. PubMed ID: 27177285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]